Barclays Boosts Kronos Worldwide (NYSE:KRO) Price Target to $8.00

Kronos Worldwide (NYSE:KRO) had its price objective hoisted by equities researchers at Barclays from $7.00 to $8.00 in a report released on Tuesday, Benzinga reports. The firm presently has an “underweight” rating on the specialty chemicals company’s stock. Barclays‘s price objective suggests a potential downside of 33.19% from the stock’s current price.

A number of other brokerages also recently weighed in on KRO. StockNews.com upgraded shares of Kronos Worldwide from a “sell” rating to a “hold” rating in a research report on Monday, February 26th. TheStreet upgraded shares of Kronos Worldwide from a “d+” rating to a “c-” rating in a research report on Monday, March 11th. Finally, The Goldman Sachs Group upped their price objective on shares of Kronos Worldwide from $7.00 to $8.00 and gave the stock a “sell” rating in a research report on Thursday, December 14th.

Kronos Worldwide Price Performance

NYSE:KRO opened at $11.98 on Tuesday. Kronos Worldwide has a one year low of $6.16 and a one year high of $12.33. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.49 and a current ratio of 3.01. The firm has a market cap of $1.38 billion, a price-to-earnings ratio of -27.85 and a beta of 1.17. The firm’s fifty day moving average is $9.71 and its two-hundred day moving average is $8.79.

Kronos Worldwide (NYSE:KRO) last posted its quarterly earnings results on Wednesday, March 6th. The specialty chemicals company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.02. Kronos Worldwide had a negative net margin of 2.95% and a negative return on equity of 5.73%. The company had revenue of $400.10 million for the quarter, compared to analyst estimates of $404.94 million. Research analysts expect that Kronos Worldwide will post 0.33 EPS for the current year.

Institutional Trading of Kronos Worldwide

Large investors have recently bought and sold shares of the business. UBS Asset Management Americas Inc. grew its stake in shares of Kronos Worldwide by 1.8% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 39,698 shares of the specialty chemicals company’s stock valued at $730,000 after buying an additional 692 shares during the period. BNP Paribas Arbitrage SA grew its stake in shares of Kronos Worldwide by 25.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 5,256 shares of the specialty chemicals company’s stock valued at $97,000 after buying an additional 1,073 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Kronos Worldwide by 0.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 165,792 shares of the specialty chemicals company’s stock valued at $1,447,000 after buying an additional 1,143 shares during the period. Advisor Group Holdings Inc. grew its stake in shares of Kronos Worldwide by 13.9% in the 4th quarter. Advisor Group Holdings Inc. now owns 10,193 shares of the specialty chemicals company’s stock valued at $95,000 after buying an additional 1,245 shares during the period. Finally, Raymond James & Associates grew its stake in shares of Kronos Worldwide by 2.3% in the 1st quarter. Raymond James & Associates now owns 60,411 shares of the specialty chemicals company’s stock valued at $938,000 after buying an additional 1,350 shares during the period. Hedge funds and other institutional investors own 15.11% of the company’s stock.

About Kronos Worldwide

Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.